KCNN4 and catecholaminergic polymorphic ventricular tachycardia: We showed recently that blockers of SK4 Ca2+-activated K+ channels depolarize the maximal diastolic potential, reduce the heart rate, and attenuate ventricular arrhythmias in CPVT.